PT1036072E - Antagonistas de receptores de trombina - Google Patents

Antagonistas de receptores de trombina

Info

Publication number
PT1036072E
PT1036072E PT98958039T PT98958039T PT1036072E PT 1036072 E PT1036072 E PT 1036072E PT 98958039 T PT98958039 T PT 98958039T PT 98958039 T PT98958039 T PT 98958039T PT 1036072 E PT1036072 E PT 1036072E
Authority
PT
Portugal
Prior art keywords
trombine
antagonists
receptors
trombine receptors
Prior art date
Application number
PT98958039T
Other languages
English (en)
Inventor
Michael F Czarniecki
Samuel Chackalamannil
Theodorus Asberom
Yan Xia
Dario Doller
Martin C Clasby
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT1036072E publication Critical patent/PT1036072E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
PT98958039T 1997-11-25 1998-11-23 Antagonistas de receptores de trombina PT1036072E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97797997A 1997-11-25 1997-11-25

Publications (1)

Publication Number Publication Date
PT1036072E true PT1036072E (pt) 2004-08-31

Family

ID=25525702

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98958039T PT1036072E (pt) 1997-11-25 1998-11-23 Antagonistas de receptores de trombina

Country Status (31)

Country Link
EP (1) EP1036072B1 (pt)
JP (2) JP3449620B2 (pt)
KR (1) KR100393492B1 (pt)
CN (2) CN1290265A (pt)
AR (1) AR017189A1 (pt)
AT (1) ATE266025T1 (pt)
AU (1) AU747204B2 (pt)
BR (1) BR9812793A (pt)
CA (1) CA2309352C (pt)
CO (1) CO4990946A1 (pt)
CZ (1) CZ298578B6 (pt)
DE (1) DE69823694T2 (pt)
DK (1) DK1036072T3 (pt)
ES (1) ES2219919T3 (pt)
HK (1) HK1031726A1 (pt)
HU (1) HUP0100607A3 (pt)
ID (1) ID24726A (pt)
IL (1) IL135797A (pt)
MY (1) MY140887A (pt)
NO (1) NO322022B1 (pt)
NZ (1) NZ504218A (pt)
PE (1) PE133799A1 (pt)
PL (1) PL195027B1 (pt)
PT (1) PT1036072E (pt)
RU (1) RU2204557C2 (pt)
SA (1) SA99190972B1 (pt)
SK (1) SK285153B6 (pt)
TR (1) TR200001480T2 (pt)
TW (1) TWI236476B (pt)
WO (1) WO1999026943A1 (pt)
ZA (1) ZA9810685B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000229961A (ja) * 1998-12-11 2000-08-22 Sagami Chem Res Center ヒドロナフト[2,3−c]フラン誘導体およびその製造方法
ATE504572T1 (de) * 1999-09-02 2011-04-15 Shionogi & Co Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
EP1764366A3 (en) * 2000-06-15 2007-10-03 Schering Corporation Thrombin receptor antagonists
US6645987B2 (en) * 2000-06-15 2003-11-11 Schering Corporation Nor-seco himbacine derivatives useful as thrombin receptor antagonists
US7235567B2 (en) 2000-06-15 2007-06-26 Schering Corporation Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
JP4251872B2 (ja) 2001-04-19 2009-04-08 エーザイ・アール・アンド・ディー・マネジメント株式会社 2−イミノイミダゾール誘導体(2)
EP2062890B1 (en) * 2002-04-16 2011-01-05 Schering Corporation Tricyclic thrombin receptor antagonist
JP4549970B2 (ja) 2003-02-19 2010-09-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 環状ベンズアミジン誘導体の製造方法
JPWO2005108370A1 (ja) 2004-04-16 2008-03-21 味の素株式会社 ベンゼン化合物
CN1984905B (zh) * 2004-05-28 2011-06-22 先灵公司 作为凝血酶受体拮抗剂的约束喜巴辛类似物
MX2007004197A (es) * 2004-10-08 2007-06-15 Schering Corp Antagonistas del receptor de trombina.
AR056919A1 (es) * 2005-01-14 2007-11-07 Schering Corp SíNTESIS EXO- Y DIASTEREO- SELECTIVAS DE ANÁLOGOS DE HIMBACINA
ES2535534T3 (es) 2005-01-14 2015-05-12 Merck Sharp & Dohme Corp. Una síntesis exo-selectiva de los análogos de himbacina
EP1853592B1 (en) * 2005-01-14 2011-03-02 Schering Corporation Synthesis of himbacine analogs
TWI367112B (en) * 2006-06-30 2012-07-01 Schering Corp Immediate-release tablet formulations of a thrombin receptor antagonist
JP2010505842A (ja) * 2006-10-04 2010-02-25 シェーリング コーポレイション トロンビン受容体拮抗薬としての二環式誘導体および三環式誘導体
WO2011128421A1 (de) 2010-04-16 2011-10-20 Sanofi Trizyklische pyridyl-vinyl-pyrrole als par1-inhibitoren
ES2527535T3 (es) 2010-04-16 2015-01-26 Sanofi Piridil-vinil-pirazolo-quinolinas como inhibidores de PAR1
CN108658910B (zh) * 2017-03-29 2020-11-03 北京新领先医药科技发展有限公司 一种沃拉帕沙中间体1-α的制备方法
CN113387947B (zh) * 2021-07-12 2022-07-01 中国科学院成都生物研究所 调节雌激素受体合成活性的吡唑并吡啶衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106197A (en) * 1992-07-30 1999-11-30 Cor Therapeutics Inc Agagonists for the rhombin receptors and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
CO4990946A1 (es) 2000-12-26
AU747204B2 (en) 2002-05-09
TR200001480T2 (tr) 2000-09-21
DE69823694D1 (de) 2004-06-09
ES2219919T3 (es) 2004-12-01
WO1999026943A1 (en) 1999-06-03
CZ298578B6 (cs) 2007-11-14
NO20002659D0 (no) 2000-05-24
CA2309352C (en) 2005-01-25
AU1415899A (en) 1999-06-15
NZ504218A (en) 2002-04-26
ATE266025T1 (de) 2004-05-15
TWI236476B (en) 2005-07-21
PE133799A1 (es) 2000-01-10
CA2309352A1 (en) 1999-06-03
NO322022B1 (no) 2006-08-07
PL341114A1 (en) 2001-03-26
KR20010032439A (ko) 2001-04-25
ID24726A (id) 2000-08-03
NO20002659L (no) 2000-07-24
BR9812793A (pt) 2000-10-17
SK285153B6 (sk) 2006-07-07
HK1031726A1 (en) 2001-06-22
JP2001524479A (ja) 2001-12-04
DK1036072T3 (da) 2004-09-06
IL135797A0 (en) 2001-05-20
KR100393492B1 (ko) 2003-08-02
MY140887A (en) 2010-01-29
SA99190972B1 (ar) 2006-07-30
IL135797A (en) 2003-09-17
HUP0100607A2 (hu) 2002-05-29
SK7592000A3 (en) 2001-02-12
JP2003128670A (ja) 2003-05-08
EP1036072B1 (en) 2004-05-06
PL195027B1 (pl) 2007-08-31
CN101274929A (zh) 2008-10-01
AR017189A1 (es) 2001-08-22
ZA9810685B (en) 1999-12-23
JP3449620B2 (ja) 2003-09-22
CN1290265A (zh) 2001-04-04
RU2204557C2 (ru) 2003-05-20
CZ20001856A3 (cs) 2000-10-11
DE69823694T2 (de) 2005-04-21
HUP0100607A3 (en) 2002-06-28
EP1036072A1 (en) 2000-09-20

Similar Documents

Publication Publication Date Title
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DE69734833D1 (de) Vitronektin rezeptor antagonisten
PT1131291E (pt) Antagonistas iii do receptor 4-aroil-piperidin-ccr-3
NO20001100D0 (no) IL-8 reseptorantagonister
DE69833073D1 (de) CCR-3-Rezeptor-Antagonisten
ID23168A (id) Reseptor anatagonis vitronektin
PT802910E (pt) Agonistas/antagonistas de estrogenio
PT1036072E (pt) Antagonistas de receptores de trombina
ID16742A (id) Antagonis reseptor endotelin
DK0741133T3 (da) Adhæsionsreceptorantagonister
NO950606D0 (no) Adhesjonsreseptor-antagonister
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
DE69838874D1 (de) Il-8 rezeptor-antagonisten
DE69831413T2 (de) Il-8 rezeptor antagonisten
DE69824837D1 (de) Il-8-rezeptor-antagonisten
PT964867E (pt) Antagonistas da taquicinima
ID22978A (id) Antagonis reseptor endotelin
SE9703745D0 (sv) New receptors
DE59503324D1 (de) Adhäsionsrezeptor-Antagonisten
SE9803428D0 (sv) Blocking of alfa2beta1-receptors